Genetic Variability of the mTOR Pathway and Prostate Cancer Risk
Author Information
Author(s): Campa Daniele, Hüsing Anika, Stein Angelika, Dostal Lucie, Boeing Heiner, Pischon Tobias, Tjønneland Anne, Roswall Nina, Overvad Kim, Østergaard Jane Nautrup, Rodríguez Laudina, Sala Núria, Sánchez Maria-José, Larrañaga Nerea, Huerta José María, Barricarte Aurelio, Khaw Kay-Tee, Wareham Nicholas, Travis Ruth C., Allen Naomi E., Lagiou Pagona, Trichopoulou Antonia, Trichopoulos Dimitrios, Palli Domenico, Sieri Sabina, Tumino Rosario, Sacerdote Carlotta, van Kranen Henk, Bueno-de-Mesquita H. Bas, Hallmans Göran, Johansson Mattias, Romieu Isabelle, Jenab Mazda, Cox David G., Siddiq Afshan, Riboli Elio, Canzian Federico, Kaaks Rudolf
Primary Institution: German Cancer Research Center (DKFZ), Heidelberg, Germany
Hypothesis
Genes in the mTOR pathway and genes of the p53 pathway that directly relate to mTOR may be centrally implicated in prostate carcinogenesis.
Conclusion
The study found an association with prostate cancer risk for two SNPs in the PRKCI gene, suggesting a potential genetic influence on susceptibility to prostate cancer.
Supporting Evidence
- Two SNPs in the PRKCI gene were associated with a decreased risk of prostate cancer.
- The study included a total of 815 prostate cancer cases and 1,266 controls.
- Findings were replicated in an independent population of 838 prostate cancer cases and 943 controls.
- Statistical analysis showed significant associations at a threshold of p<0.01.
- Results were consistent with previous studies on the mTOR pathway and cancer risk.
Takeaway
Scientists looked at genes that might affect the risk of getting prostate cancer and found two specific gene changes that could lower that risk.
Methodology
The study analyzed 1,084 tagging SNPs in 67 genes involved in the mTOR pathway in a case-control study of prostate cancer.
Potential Biases
The study did not observe major variations in allele frequencies across countries, which may mitigate bias risks.
Limitations
The study's findings may be limited by the large number of tests performed and potential confounding by population stratification.
Participant Demographics
The majority of participants were of European ('Caucasian') origin, aged 35–69.
Statistical Information
P-Value
p=0.0028 for rs4955720; p=0.0014 for rs546950
Confidence Interval
95% CI 0.76–0.94 for rs546950; 95% CI 0.78–0.93 for rs4955720
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website